Siemens filed more patents than any other company in Germany in 2021, climbing to fifth place in the European Patent Office's applicant ranking.
The inventors who work at Siemens lay the foundation for progress and create sustainable value for customers and society - wich is Siemens' purpose.
Dr. Roland Busch, President and CEO of Siemens AG, said: 'Siemens continues to lead German companies in the European patent rankings. Our inventors filed around 6% more patent applications in 2021. In research and development, we're focusing our efforts on sustainability and digitalization. And we are doing so with success: We're particularly strong when it comes to new patents in these fields. Digital technologies are, after all, extremely relevant for platforms in the B2B sector, and these platforms are an essential part of our customers' and partners' transformations.'
U.S. business magazine Fast Company recognizes Siemens as one of the world's most innovative companies
The recognition that Siemens has been earning for its innovation capabilities is also reflected in an award bestowed by the American business magazine Fast Company, which named Siemens one of the world's most innovative companies. This monthly publication, which focuses on technology, business and design, honored Siemens for the work it performed in 2021 to convert BioNTech's production facility in Marburg, Germany, to manufacture lifesaving COVID-19 vaccines in less than half the expected time.
As BioNTech prepared to retool its Marburg production facility for mass production of the COVID-19 mRNA vaccine, the company turned to Siemens. Siemens was able to complete the plant in five months while fully digitizing the process. From production documentation to the weighing of vials - steps that were previously done manually - Siemens upgraded the plant to be able to produce up to 625 million doses. Siemens also became BioNTech's partner when the company wanted to build new production facilities, including one in Singapore, in the summer of 2021.
Siemens honors inventor of the year 2021
Since 1995, Siemens has presented its Inventors of the Year award annually to outstanding employees in research and development whose inventions contribute significantly to the company's success. Since 2016, these awards have also been presented to researchers outside the company.
For the past year, particularly resourceful researchers were again honored as 'Inventor of the Year 2021' in January 2022. The spectrum of inventions ranges from hydrogen-powered trains and a clever solution to stabilize electricity grids with a high proportion of renewable energies to a cancer therapy that is available to many more patients.
Siemens filed around 2,500 patents worldwide in fiscal 2021. In total, the company holds more than 43,400 granted patents. Employees reported 4,483 inventions during the period - that's approximately 20 inventions per working day.
Siemens AG (Berlin and Munich) is a technology company focused on industry, infrastructure, transport, and healthcare. From more resource-efficient factories, resilient supply chains, and smarter buildings and grids, to cleaner and more comfortable transportation as well as advanced healthcare, the company creates technology with purpose adding real value for customers. By combining the real and the digital worlds, Siemens empowers its customers to transform their industries and markets, helping them to transform the everyday for billions of people. Siemens also owns a majority stake in the publicly listed company Siemens Healthineers, a globally leading medical technology provider shaping the future of healthcare. In addition, Siemens holds a minority stake in Siemens Energy, a global leader in the transmission and generation of electrical power. In fiscal 2021, which ended on September 30, 2021, the Siemens Group generated revenue of EUR62.3 billion and net income of EUR6.7 billion. As of September 30, 2021, the company had around 303,000 employees worldwide.
Contact:
Bernhard Wardin
Tel: +49 173 3270510
Email: bernhard.wardin@siemens.com
SIEMENS AG 
